Cetuximab in Treating Patients With Stage IV Colorectal Cancer

NCT00020930 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: cetuximab

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]